[Retracted] Unilateral Multifocality and Bilaterality Could Be Two Different Multifocal Entities in Patients with Papillary Thyroid Microcarcinoma
Table 4
Clinicopathological factors between four groups classified by different multifocality status.
Variables
Groups
Group I () (%)
Group II () (%)
Group III () (%)
Group IV () (%)
value
Age (≥45 vs. <45)
347/366 (48.7)
40/41 (49.4)
30/42 (41.7)
42/41 (50.6)
0.678
Gender (male vs. female)
157/556 (22)
15/66 (18.5)
21/51 (29.2)
14/69 (16.9)
0.261
Tumor size (>0.5 vs. ≤0.5)
360/353 (50.5)
56/25 (69.1)
38/34 (52.8)
53/30 (63.9)
0.003
Capsular invasion
125/588 (17.5)
15/66 (18.5)
13/59 (18.1)
17/66 (20.5)
0.927
Extrathyroidal invasion
17/696 (2.4)
2/79 (2.5)
0/72 (0)
2/81 (2.4)
0.622
Hashimoto
133/580 (18.7)
21/60 (25.9)
8/64 (11.1)
17/66 (20.5)
0.131
Simple goiter
328/385 (46)
19/62 (23.5)
41/31 (56.9)
26/57 (31.3)
<0.001
CNM
209/504 (29.3)
26/55 (32.1)
28/44 (38.9)
36/47 (43.4)
0.032
LNM
31/682 (4.3)
2/79 (2.5)
4/68 (5.6)
7/76 (8.4)
0.266
Recurrence
3/710 (0.4)
1/80 (1.2)
2/70 (2.8)
3/80 (3.6)
0.021
Group I: single lesion; group II: univocal bilaterality-single lesion in each lobe; group III: unilateral multifocality; group IV: unilateral multifocality and bilaterality coexist.
